Revealing the Mechanisms of Qilongtian Capsules in the Treatment of Chronic Obstructive Pulmonary Disease Based on Integrated Network Pharmacology, Molecular Docking, and In Vivo Experiments

肺病 体内 药理学 对接(动物) 医学 疾病 计算生物学 内科学 生物 生物技术 护理部
作者
Ying Xie,Zhengyan Li,Yiyao Liang,Tong Zhou,Xiaolin Yuan,Xuerong Su,Zhitong Zhang,Jiuba Zhang,Yi Wan,Lianlin Su,Tulin Lu,Xiaoli Zhao,Yi Fu
出处
期刊:ACS omega [American Chemical Society]
卷期号:9 (30): 32455-32468 被引量:2
标识
DOI:10.1021/acsomega.3c10163
摘要

The Qilongtian capsule (QLT) is a Chinese patent medicine that has been approved for the treatment of chronic obstructive pulmonary disease (COPD). However, the precise pharmacodynamic material basis and molecular mechanism have not been well illustrated. In this study, we identified the effect of QLT on COPD through a cigarette smoke extract (CSE)/lipopolysaccharide (LPS) induced COPD mice model. The absorption of blood components in QLT were identified using ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Network pharmacology was used to predict the potential targets and therapeutic mechanisms of QLT, which were further validated using in vivo experiments and molecular docking. Pharmacodynamic studies revealed that QLT could ameliorate pulmonary function and pulmonary pathology, reduce collagen fiber accumulation, and attenuate inflammatory responses in mice with CSE/LPS induced COPD. A total of 21 components of QLT absorbed in the blood were detected. Network pharmacology analysis indicated that TNF, IL-6, EGFR, and AKT1 may be the core targets, mainly involving the MAPK signaling pathway. Besides, Sachaloside II, Ginsenoside Rh1, Ginsenoside F1, Rosiridin, and Ginsenoside Rf were the key compounds. Molecular docking results showed that the key components could spontaneously bind to EGFR and MAPK to form a relatively stable conformation. In vivo experiments revealed that QLT could suppress the activation of the EGFR/MAPK signaling pathway, thereby improving lung injury in mice with COPD. Overall, these findings provide evidence for the treatment of COPD with QLT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
zrf发布了新的文献求助100
1秒前
李健的粉丝团团长的应助被mjq采纳,获得10
1秒前
NexusExplorer的应助被ECCE采纳,获得10
1秒前
牧木完成签到,获得积分10
1秒前
影逐光发布了新的文献求助10
1秒前
2秒前
传奇3的应助被hahage采纳,获得50
2秒前
精明梦柏完成签到,获得积分10
2秒前
2秒前
核桃发布了新的文献求助10
2秒前
勇猛的小qin完成签到 ,获得积分10
2秒前
冷酷的问梅完成签到,获得积分10
3秒前
科研通AI2S的应助被curry采纳,获得10
3秒前
自信谷冬发布了新的文献求助10
3秒前
宁灭龙发布了新的文献求助10
3秒前
4秒前
明理鸿完成签到,获得积分10
4秒前
如何让人发布了新的文献求助10
4秒前
5秒前
5秒前
顾矜的应助被wang采纳,获得30
5秒前
5秒前
5秒前
6秒前
mm完成签到,获得积分10
6秒前
7秒前
jiangjiang完成签到,获得积分10
7秒前
yyyyyy完成签到,获得积分10
7秒前
7秒前
科研通AI2S的应助被牧木采纳,获得10
7秒前
lz完成签到,获得积分10
7秒前
WYH发布了新的文献求助10
7秒前
田好好发布了新的文献求助10
8秒前
123完成签到 ,获得积分10
8秒前
123发布了新的文献求助10
8秒前
小蘑菇的应助被谨慎的秋烟采纳,获得10
8秒前
alandan发布了新的文献求助10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155737
求助须知:如何正确求助?哪些是违规求助? 9552018
关于积分的说明 21707687
捐赠科研通 7744923
什么是DOI,文献DOI怎么找? 3426177
关于科研通互助平台的介绍 2551229
邀请新用户注册赠送积分活动 2469949